Neuralytix Expands iD3 System for Spine Surgery
Fruita, Colorado, August 12, 2026 Neuralytix, LLC announced the full commercial availability of its iD3 System, an FDA 510(k)-cleared...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Fruita, Colorado, August 12, 2026 Neuralytix, LLC announced the full commercial availability of its iD3 System, an FDA 510(k)-cleared...
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
Plantation, Florida, USA — July 24, 2026 Advita Ortho has announced the first clinical use of Equinoxe® Reverse Shoulder...
Fort Lauderdale, Fla., July 17, 2026 SS Innovations International announced that its SSi Mantra surgical robotic system will be...
SEOUL, South Korea, June 18, 2026 MediThinQ, a leading innovator in digital surgical visualization technologies, has entered into an...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
LONDON, United Kingdom, June 8, 2026 Smith+Nephew has announced the successful completion of the first clinical procedures using its...
Hong Kong, China – May 25, 2026 Cornerstone Robotics (CSR) announced that its Sentire® Endoscopic Surgical System has officially...
VAUGHAN, Ontario, May 7, 2026 Bausch + Lomb announced the European launch of its advanced Bi-Blade+â„¢ dual-port vitrectomy cutter...
DRAPER, Utah, May 4, 2026 Ortho Development Corporation (ODEV) has announced the full commercial launch of the Trivicta® Hip...
